Surgical hydrogel
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
6
NCT03123978
Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer
Phase: Phase 1
Role: Collaborator
Start: Jan 9, 2017
Completion: Apr 19, 2022
Loading map...